Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel cobalt coordination compound synthesis method offers high conversion rates for organic catalysis, ensuring reliable supply chain solutions.
Patent CN113249417B reveals a biocatalytic route for chiral cis-beta-aryl-beta-hydroxy-alpha-amino esters using KRED-Bt, offering high stereoselectivity and industrial scalability.
Patent CN113582937A details a metal-free isoxazole synthesis using TPGS-750-M in water, offering significant cost reduction and environmental benefits for pharmaceutical manufacturing.
Patent CN113582937A details a metal-free isoxazole synthesis using TPGS-750-M in water. This method offers significant cost reduction and environmental benefits for pharmaceutical manufacturing.
Patent CN107501237B reveals a cyanide-free Apalutamide synthesis. Enhance supply chain safety and reduce manufacturing costs with this novel pharmaceutical intermediate route.
Novel rearrangement process reduces cost and improves purity for pharmaceutical intermediates supply chain efficiency and commercial scalability significantly
Patent CN108359649A reveals high-selectivity alcohol dehydrogenase mutants for synthesizing chiral biaryl alcohols, offering cost reduction and supply reliability.
Patent CN118909993A reveals a high-activity imine reductase mutant for green synthesis. Achieves >99% optical purity and high space-time yield for reliable supply.
Patent CN101891746B details a novel rhodium-free route for meropenem. Discover cost-effective, high-purity carbapenem manufacturing solutions for your supply chain.
Patent CN102267893B details a high-yield Royal Jelly Acid synthesis using recyclable SiO2-Tempo and ionic liquids, offering significant cost and supply chain advantages.
Patent CN105154513A analysis reveals dynamic kinetic resolution for high-purity chiral intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN105063163A reveals enzyme-catalyzed DKR for high-purity chiral intermediates. Offers cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN104974001A details a novel cinchona alkaloid-catalyzed route for high-purity beta-branched alpha-amino esters, offering significant supply chain and cost advantages.
Patent CN111170829B details a safer, high-selectivity route for hexamethylindanol using supported Ru catalysts, offering significant cost and safety advantages for fragrance manufacturers.
Patent CN1419557A reveals a novel low-temperature process for fused imidazopyridine derivatives. Discover cost-effective manufacturing and stable crystal forms for API production.
Patent CN114230504B reveals a continuous flow method for pyrrolidone intermediates, enhancing safety and scalability for API manufacturing supply chains.
Patent CN101508662A details a green phase-transfer method yielding high-purity sec-butyl disulfide, offering significant cost reduction and supply chain reliability.
Patent CN102219803A details a novel nitrone-based route for Ezetimibe intermediates, offering superior stereocontrol and reduced raw material consumption for pharmaceutical manufacturing.
Patent CN101613666B details a novel Bacillus sp. ECU0015 strain for high-purity chiral diol production, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN111675650A details a green photo-induced synthesis for aromatic vinyl bromides. Delivers cost reduction in pharmaceutical intermediate manufacturing with high purity.